Global Market Study on Active Pharmaceutical Ingredients: Growing Prevalence of Chronic Disorders Increasing Demand for Pharmaceuticals & APIs

Mar 2021| PMR280B| Persistence Market Research

Report Highlights

Active Pharmaceutical Ingredients (API) Market - Scope of Report

A latest, revised publication by Persistence Market Research on the global active pharmaceutical ingredients (API) market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for successful growth of the market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in this research. This research study can support readers to know the demand and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the active pharmaceutical ingredients market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in this market space. Insights and wisdom presented in this study can be leveraged by shareholders in the API market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the active pharmaceutical ingredients market offers information divided into three important segments— API, end user, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

API

  • Small Molecules
  • Controlled Substances
  • Natural Opioids
  • Semi-synthetic/Synthetic Opioids
  • Non-Controlled Substances
  • NSAIDs
  • Anti-infective
  • Antimicrobial
  • Oral Anti-diabetics
  • Anti-hypertensive
  • Others
  • HPAPI
  • Peptides & Oligonucleotides
  • Carbohydrate Drugs
  • Steroidal Drugs

End User

  • Pharmaceutical Companies Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Development & Manufacturing Organizations (CDMOs)

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for APIs?
  • Which factors will induce a change in the demand for active pharmaceutical ingredients during the assessment period?
  • How will changing trends impact the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • How has COVID-19 impacted the API market?
  • What are the winning strategies of stakeholders to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends in active pharmaceutical ingredients that will impact the market?
  • How can businesses in the market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the active pharmaceutical ingredients market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the API market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the active pharmaceutical ingredients market, and makes projections on the growth prospects of the market more accurate and reliable in the study report.

  • Table 1 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 2 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 3 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Region
  • Table 4 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 5 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 6 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 7 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 8 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 9 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 10 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 11 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 12 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 13 : South Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 14 : South Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 15 : South Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 16 : East Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 17 : East Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 18 : East Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 19 : Oceania Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 20 : Oceania Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 21 : Oceania Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 22 : MEA Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Table 23 : MEA Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by API Type
  • Table 24 : MEA Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Figure 1 : Global Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) by API Type, 2021 & 2031
  • Figure 2 : Global Active Pharmaceutical Ingredients (API) Market Value Analysis (US$ Bn), 2016-2020
  • Figure 3 : Global Active Pharmaceutical Ingredients (API) Market Value Forecast (US$ Bn), 2021-2031
  • Figure 4 : Global Active Pharmaceutical Ingredients (API) Market Absolute $ Opportunity, 2021-2031
  • Figure 5 : Global Active Pharmaceutical Ingredients (API) Market Share Analysis (%) by API Type, 2021 & 2031
  • Figure 6 : Global Active Pharmaceutical Ingredients (API) Market Y-o-Y Growth (%) by, 2020-2031
  • Figure 7 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 8 : Global Active Pharmaceutical Ingredients (API) Market Share Analysis (%) by End User, 2021 & 2031
  • Figure 9 : Global Active Pharmaceutical Ingredients (API) Market Y-o-Y Growth (%) by End User, 2020-2031
  • Figure 10 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User, 2021-2031
  • Figure 11 : Global Active Pharmaceutical Ingredients (API) Market Share Analysis (%) by Region, 2021 & 2031
  • Figure 12 : Global Active Pharmaceutical Ingredients (API) Market Y-o-Y Growth (%) by Region, 2021-2031
  • Figure 13 : Global Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Region, 2021-2031
  • Figure 14 : North America Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 15 : North America Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 16 : North America Market Value Share, By Country, 2021 (E)
  • Figure 17 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 18 : North America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 19 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 20 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 21 : North America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 22 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 23 : Latin America Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 24 : Latin America Market Value Share, By Country, 2021 (E)
  • Figure 25 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 26 : Latin America Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 27 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 28 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-203128
  • Figure 29 : Latin America Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 30 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 31 : Europe Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 32 : Europe Market Value Share, By Country, 2021 (E)
  • Figure 33 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 34 : Europe Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 35 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 36 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 37 : Europe Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 38 : South Asia Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 39 : South Asia Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 40 : South Asia Market Value Share, By Country, 2021 (E)
  • Figure 41 : South Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 42 : South Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 43 : South Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 44 : South Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 45 : South Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 46 : East Asia Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 47 : East Asia Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 48 : East Asia Market Value Share, By Country, 2021 (E)
  • Figure 49 : East Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 50 : East Asia Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 51 : East Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 52 : East Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 53 : East Asia Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 54 : Oceania Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 55 : Oceania Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 56 : Oceania Market Value Share, By Country, 2021 (E)
  • Figure 57 : Oceania Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 58 : Oceania Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 59 : Oceania Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 60 : Oceania Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 61 : Oceania Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 62 : MEA Active Pharmaceutical Ingredients (API) Market Value Share, By API Type, 2021 (E)
  • Figure 63 : MEA Active Pharmaceutical Ingredients (API) Market Value Share, By End User, 2021 (E)
  • Figure 64 : MEA Market Value Share, By Country, 2021 (E)
  • Figure 65 : MEA Active Pharmaceutical Ingredients (API) Market Value (US$ Bn), 2016 - 2020
  • Figure 66 : MEA Active Pharmaceutical Ingredients (API) Market Value (US$ Bn) Forecast, 2021-2031
  • Figure 67 : MEA Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by API Type, 2021-2031
  • Figure 68 : MEA Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by End User , 2021-2031
  • Figure 69 : MEA Active Pharmaceutical Ingredients (API) Market Attractiveness Analysis by Country, 2021-2031
  • Figure 70 : U.S. Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 71 : U.S. Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 72 : Global Vs. U.S. Growth Comparison
  • Figure 73 : Canada Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 74 : Canada Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 75 : Global Vs. Canada Growth Comparison
  • Figure 76 : Mexico Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 77 : Mexico Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 78 : Global Vs. Mexico Growth Comparison
  • Figure 79 : Brazil Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 80 : Brazil Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 81 : Global Vs. Brazil Growth Comparison
  • Figure 82 : U.K. Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 83 : U.K. Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 84 : Global Vs. U.K. Growth Comparison
  • Figure 85 : Germany Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 86 : Germany Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 87 : Global Vs. Germany Growth Comparison
  • Figure 88 : France Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 89 : France Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 90 : Global Vs. France Growth Comparison
  • Figure 91 : Italy Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 92 : Italy Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 93 : Global Vs. Italy Growth Comparison
  • Figure 94 : Spain Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 95 : Spain Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 96 : Global Vs. Spain Growth Comparison
  • Figure 97 : Russia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 98 : Russia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 99 : Global Vs. Russia Growth Comparison
  • Figure 100 : China Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 101 : China Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 102 : Global Vs. China Growth Comparison
  • Figure 103 : Japan Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 104 : Japan Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 105 : Global Vs. Japan Growth Comparison
  • Figure 106 : South Korea Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 107 : South Korea Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 108 : Global Vs. South Korea Growth Comparison
  • Figure 109 : India Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 110 : India Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 111 : Global Vs. India Growth Comparison
  • Figure 112 : Thailand Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 113 : Thailand Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 114 : Global Vs. Thailand Growth Comparison
  • Figure 115 : Indonesia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 116 : Indonesia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 117 : Global Vs. Indonesia Growth Comparison
  • Figure 118 : Malaysia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 119 : Malaysia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 120 : Global Vs. Malaysia Growth Comparison
  • Figure 121 : Australia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 122 : Australia Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 123 : Global Vs. Australia Growth Comparison
  • Figure 124 : New Zealand Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 125 : New Zealand Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 126 : Global Vs. New Zealand Growth Comparison
  • Figure 127 : GCC Countries Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 128 : GCC Countries Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 129 : Global Vs. GCC Countries Growth Comparison
  • Figure 130 : Turkey Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 131 : Turkey Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 132 : Global Vs. Turkey Growth Comparison
  • Figure 133 : South Africa Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By Product Type, 2020 &2031
  • Figure 134 : South Africa Active Pharmaceutical Ingredients (API) Market Share Analysis (%), By End User, 2020 &2031
  • Figure 135 : Global Vs. South Africa Growth Comparison

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report